DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 10 of 48 descriptions
Filter by
Reset
|
No.
Drug (Description in trials)
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
Disease ID
1
Group 2 ustekinumab 130 mg
(
Stelara
(TN))
[1]
Ustekinumab
Ustekinumab
(
Stelara
)
[1]
Ustekinumab
Ustekinumab
(
Stelara
(TN))
💬
1. Group 2 ustekinumab 130 mg
×
Name
Other Names
Ustekinumab
Ustekinumab (USAN/INN)
Ustekinumab (genetical recombination) (JAN)
Stelara (TN)
[3]
IL12A
IL12A
,
IL12B
,
IL23A
💬
1. Group 2 ustekinumab 130 mg
×
Name
Full Name
IL12A
interleukin 12A
IL12B
interleukin 12B
IL23A
interleukin 23 subunit alpha
[28]
African trypanosomiasis
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Herpes simplex virus 1 infection
,
Inflammatory bowel disease
,
Influenza A
,
JAK-STAT signaling pathway
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Malaria
,
Measles
,
Pathways in cancer
,
Pertussis
,
Proteoglycans in cancer
,
RIG-I-like receptor signaling pathway
,
Rheumatoid arthritis
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Toxoplasmosis
,
Tuberculosis
,
Type I diabetes mellitus
💬
[28]
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lecti
...
[1]
96
96
💬
1. Group 2 ustekinumab 130 mg
×
Disease ID
Name
96
Crohn disease
2
Group 3: ustekinumab approximately 6 mg/kg
(
Stelara
(TN))
[1]
Ustekinumab
Ustekinumab
(
Stelara
)
[1]
Ustekinumab
Ustekinumab
(
Stelara
(TN))
💬
2. Group 3: ustekinumab approximately 6 mg/kg
×
Name
Other Names
Ustekinumab
Ustekinumab (USAN/INN)
Ustekinumab (genetical recombination) (JAN)
Stelara (TN)
[3]
IL12A
IL12A
,
IL12B
,
IL23A
💬
2. Group 3: ustekinumab approximately 6 mg/kg
×
Name
Full Name
IL12A
interleukin 12A
IL12B
interleukin 12B
IL23A
interleukin 23 subunit alpha
[28]
African trypanosomiasis
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Herpes simplex virus 1 infection
,
Inflammatory bowel disease
,
Influenza A
,
JAK-STAT signaling pathway
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Malaria
,
Measles
,
Pathways in cancer
,
Pertussis
,
Proteoglycans in cancer
,
RIG-I-like receptor signaling pathway
,
Rheumatoid arthritis
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Toxoplasmosis
,
Tuberculosis
,
Type I diabetes mellitus
💬
[28]
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lecti
...
[1]
96
96
💬
2. Group 3: ustekinumab approximately 6 mg/kg
×
Disease ID
Name
96
Crohn disease
3
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab
(
Stelara
(TN))
[5]
Adalimumab
Adalimumab
,
Golimumab
,
Infliximab
,
Ustekinumab
(
Stelara
),
Vedolizumab
[5]
Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
,
Vedolizumab
,
Ustekinumab
(
Stelara
(TN))
💬
3. Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab
×
Name
Other Names
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination) (JAN)
Adalimumab (genetical recombination) [Adalimumab biosimilar 1] (JAN)
Adalimumab (genetical recombination) [Adalimumab biosimilar 2] (JAN)
Adalimumab (genetical recombination) [Adalimumab biosimilar 3] (JAN)
Adalimumab-adaz
Adalimumab-adbm
Adalimumab-afzb
Adalimumab-atto
Adalimumab-bwwd
Adalimumab-fkjp
Humira (TN)
Abrilada (TN)
Amjevita (TN)
Cyltezo (TN)
Hadlima (TN)
Hyrimoz (TN)
Infliximab
Infliximab (USAN/INN)
Infliximab (genetical recombination) (JAN)
Infliximab (genetical recombination) [Infliximab biosimilar 1] (JAN)
Infliximab (genetical recombination) [Infliximab biosimilar 2] (JAN)
Infliximab (genetical recombination) [Infliximab biosimilar 3] (JAN)
Infliximab-dyyb
Infliximab-abda
Infliximab-axxq
Remicade (TN)
Inflectra (TN)
Renflexis (TN)
Avsola (TN)
Golimumab
Golimumab (USAN/INN)
Golimumab (genetical recombination) (JAN)
Simponi (TN)
SIMPONI ARIA
Vedolizumab
Vedolizumab (USAN)
Vedolizumab (genetical recombination) (JAN)
Entyvio (TN)
Ustekinumab
Ustekinumab (USAN/INN)
Ustekinumab (genetical recombination) (JAN)
Stelara (TN)
[6]
IL12A
IL12A
,
IL12B
,
IL23A
,
ITGA4
,
ITGB7
,
TNF
💬
3. Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab
×
Name
Full Name
IL12A
interleukin 12A
IL12B
interleukin 12B
IL23A
interleukin 23 subunit alpha
ITGA4
integrin subunit alpha 4
ITGB7
integrin subunit beta 7
TNF
tumor necrosis factor
[81]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Alzheimer disease
,
Amoebiasis
,
Amyotrophic lateral sclerosis
,
Antifolate resistance
,
Antigen processing and presentation
,
Apoptosis
,
Arrhythmogenic right ventricular cardiomyopathy
,
Asthma
,
C-type lectin receptor signaling pathway
,
Cell adhesion molecules
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Dilated cardiomyopathy
,
ECM-receptor interaction
,
Epstein-Barr virus infection
,
Fc epsilon RI signaling pathway
,
Fluid shear stress and atherosclerosis
,
Focal adhesion
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human immunodeficiency virus 1 infection
,
Human papillomavirus infection
,
Hypertrophic cardiomyopathy
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Influenza A
,
Insulin resistance
,
Intestinal immune network for IgA production
,
JAK-STAT signaling pathway
,
Legionellosis
,
Leishmaniasis
,
Leukocyte transendothelial migration
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
Measles
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Natural killer cell mediated cytotoxicity
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
PI3K-Akt signaling pathway
,
Pathogenic Escherichia coli infection
,
Pathways in cancer
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Proteoglycans in cancer
,
RIG-I-like receptor signaling pathway
,
Regulation of actin cytoskeleton
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
Sphingolipid signaling pathway
,
Systemic lupus erythematosus
,
T cell receptor signaling pathway
,
TGF-beta signaling pathway
,
TNF signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Toxoplasmosis
,
Transcriptional misregulation in cancer
,
Tuberculosis
,
Type I diabetes mellitus
,
Type II diabetes mellitus
,
Viral protein interaction with cytokine and cytokine receptor
,
Yersinia infection
,
mTOR signaling pathway
💬
[81]
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
African
...
[2]
96
96
,
97
💬
3. Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab
×
Disease ID
Name
96
Crohn disease
97
Ulcerative colitis
4
Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab
(
Stelara
(TN))
[5]
Adalimumab
Adalimumab
,
Golimumab
,
Infliximab
,
Ustekinumab
(
Stelara
),
Vedolizumab
[5]
Adalimumab
Adalimumab
,
Infliximab
,
Golimumab
,
Vedolizumab
,
Ustekinumab
(
Stelara
(TN))
💬
4. Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab
×
Name
Other Names
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination) (JAN)
Adalimumab (genetical recombination) [Adalimumab biosimilar 1] (JAN)
Adalimumab (genetical recombination) [Adalimumab biosimilar 2] (JAN)
Adalimumab (genetical recombination) [Adalimumab biosimilar 3] (JAN)
Adalimumab-adaz
Adalimumab-adbm
Adalimumab-afzb
Adalimumab-atto
Adalimumab-bwwd
Adalimumab-fkjp
Humira (TN)
Abrilada (TN)
Amjevita (TN)
Cyltezo (TN)
Hadlima (TN)
Hyrimoz (TN)
Infliximab
Infliximab (USAN/INN)
Infliximab (genetical recombination) (JAN)
Infliximab (genetical recombination) [Infliximab biosimilar 1] (JAN)
Infliximab (genetical recombination) [Infliximab biosimilar 2] (JAN)
Infliximab (genetical recombination) [Infliximab biosimilar 3] (JAN)
Infliximab-dyyb
Infliximab-abda
Infliximab-axxq
Remicade (TN)
Inflectra (TN)
Renflexis (TN)
Avsola (TN)
Golimumab
Golimumab (USAN/INN)
Golimumab (genetical recombination) (JAN)
Simponi (TN)
SIMPONI ARIA
Vedolizumab
Vedolizumab (USAN)
Vedolizumab (genetical recombination) (JAN)
Entyvio (TN)
Ustekinumab
Ustekinumab (USAN/INN)
Ustekinumab (genetical recombination) (JAN)
Stelara (TN)
[6]
IL12A
IL12A
,
IL12B
,
IL23A
,
ITGA4
,
ITGB7
,
TNF
💬
4. Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab
×
Name
Full Name
IL12A
interleukin 12A
IL12B
interleukin 12B
IL23A
interleukin 23 subunit alpha
ITGA4
integrin subunit alpha 4
ITGB7
integrin subunit beta 7
TNF
tumor necrosis factor
[81]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Alzheimer disease
,
Amoebiasis
,
Amyotrophic lateral sclerosis
,
Antifolate resistance
,
Antigen processing and presentation
,
Apoptosis
,
Arrhythmogenic right ventricular cardiomyopathy
,
Asthma
,
C-type lectin receptor signaling pathway
,
Cell adhesion molecules
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Dilated cardiomyopathy
,
ECM-receptor interaction
,
Epstein-Barr virus infection
,
Fc epsilon RI signaling pathway
,
Fluid shear stress and atherosclerosis
,
Focal adhesion
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human immunodeficiency virus 1 infection
,
Human papillomavirus infection
,
Hypertrophic cardiomyopathy
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Influenza A
,
Insulin resistance
,
Intestinal immune network for IgA production
,
JAK-STAT signaling pathway
,
Legionellosis
,
Leishmaniasis
,
Leukocyte transendothelial migration
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
Measles
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Natural killer cell mediated cytotoxicity
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
PI3K-Akt signaling pathway
,
Pathogenic Escherichia coli infection
,
Pathways in cancer
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Proteoglycans in cancer
,
RIG-I-like receptor signaling pathway
,
Regulation of actin cytoskeleton
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
Sphingolipid signaling pathway
,
Systemic lupus erythematosus
,
T cell receptor signaling pathway
,
TGF-beta signaling pathway
,
TNF signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Toxoplasmosis
,
Transcriptional misregulation in cancer
,
Tuberculosis
,
Type I diabetes mellitus
,
Type II diabetes mellitus
,
Viral protein interaction with cytokine and cytokine receptor
,
Yersinia infection
,
mTOR signaling pathway
💬
[81]
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
African
...
[1]
97
97
💬
4. Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab
×
Disease ID
Name
97
Ulcerative colitis
5
Prednisone and ustekinumab treatment
(
Stelara
(TN))
[2]
Prednisone
Prednisone
,
Ustekinumab
(
Stelara
)
[2]
Prednisone
Prednisone
,
Ustekinumab
(
Stelara
(TN))
💬
5. Prednisone and ustekinumab treatment
×
Name
Other Names
Prednisone
Prednisone (USP)
Prednisone monohydrate
Deltasone (TN)
Meticorten (TN)
Rayos (TN)
Ustekinumab
Ustekinumab (USAN/INN)
Ustekinumab (genetical recombination) (JAN)
Stelara (TN)
[4]
IL12A
IL12A
,
IL12B
,
IL23A
,
NR3C1
💬
5. Prednisone and ustekinumab treatment
×
Name
Full Name
IL12A
interleukin 12A
IL12B
interleukin 12B
IL23A
interleukin 23 subunit alpha
NR3C1
nuclear receptor subfamily 3 group C member 1
[29]
African trypanosomiasis
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Herpes simplex virus 1 infection
,
Inflammatory bowel disease
,
Influenza A
,
JAK-STAT signaling pathway
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Malaria
,
Measles
,
Neuroactive ligand-receptor interaction
,
Pathways in cancer
,
Pertussis
,
Proteoglycans in cancer
,
RIG-I-like receptor signaling pathway
,
Rheumatoid arthritis
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Toxoplasmosis
,
Tuberculosis
,
Type I diabetes mellitus
💬
[29]
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lecti
...
[1]
41
41
💬
5. Prednisone and ustekinumab treatment
×
Disease ID
Name
41
Giant cell arteritis
6
Stelara
[1]
Ustekinumab
Ustekinumab
(
Stelara
)
[1]
Ustekinumab
Ustekinumab
(
Stelara
(TN))
💬
6.
Stelara
×
Name
Other Names
Ustekinumab
Ustekinumab (USAN/INN)
Ustekinumab (genetical recombination) (JAN)
Stelara (TN)
[3]
IL12A
IL12A
,
IL12B
,
IL23A
💬
6.
Stelara
×
Name
Full Name
IL12A
interleukin 12A
IL12B
interleukin 12B
IL23A
interleukin 23 subunit alpha
[28]
African trypanosomiasis
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Herpes simplex virus 1 infection
,
Inflammatory bowel disease
,
Influenza A
,
JAK-STAT signaling pathway
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Malaria
,
Measles
,
Pathways in cancer
,
Pertussis
,
Proteoglycans in cancer
,
RIG-I-like receptor signaling pathway
,
Rheumatoid arthritis
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Toxoplasmosis
,
Tuberculosis
,
Type I diabetes mellitus
💬
[28]
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lecti
...
[6]
49
49
,
56
,
96
,
97
,
269
,
271
💬
6.
Stelara
×
Disease ID
Name
49
Systemic lupus erythematosus
56
Behcet disease
96
Crohn disease
97
Ulcerative colitis
269
Pyogenic arthritis
271
Ankylosing spondylitis
7
Stelara
(ustekinumab)
[1]
Ustekinumab
Ustekinumab
(
Stelara
)
[1]
Ustekinumab
Ustekinumab
(
Stelara
(TN))
💬
7.
Stelara
(ustekinumab)
×
Name
Other Names
Ustekinumab
Ustekinumab (USAN/INN)
Ustekinumab (genetical recombination) (JAN)
Stelara (TN)
[3]
IL12A
IL12A
,
IL12B
,
IL23A
💬
7.
Stelara
(ustekinumab)
×
Name
Full Name
IL12A
interleukin 12A
IL12B
interleukin 12B
IL23A
interleukin 23 subunit alpha
[28]
African trypanosomiasis
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Herpes simplex virus 1 infection
,
Inflammatory bowel disease
,
Influenza A
,
JAK-STAT signaling pathway
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Malaria
,
Measles
,
Pathways in cancer
,
Pertussis
,
Proteoglycans in cancer
,
RIG-I-like receptor signaling pathway
,
Rheumatoid arthritis
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Toxoplasmosis
,
Tuberculosis
,
Type I diabetes mellitus
💬
[28]
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lecti
...
[1]
65
65
💬
7.
Stelara
(ustekinumab)
×
Disease ID
Name
65
Primary immunodeficiency
8
STELARA
- 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO
STELARA
- 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLA
...
[1]
Ustekinumab
Ustekinumab
(
Stelara
)
[1]
Ustekinumab
Ustekinumab
(
Stelara
(TN))
💬
8.
STELARA
- 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO
×
Name
Other Names
Ustekinumab
Ustekinumab (USAN/INN)
Ustekinumab (genetical recombination) (JAN)
Stelara (TN)
[3]
IL12A
IL12A
,
IL12B
,
IL23A
💬
8.
STELARA
- 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO
×
Name
Full Name
IL12A
interleukin 12A
IL12B
interleukin 12B
IL23A
interleukin 23 subunit alpha
[28]
African trypanosomiasis
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Herpes simplex virus 1 infection
,
Inflammatory bowel disease
,
Influenza A
,
JAK-STAT signaling pathway
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Malaria
,
Measles
,
Pathways in cancer
,
Pertussis
,
Proteoglycans in cancer
,
RIG-I-like receptor signaling pathway
,
Rheumatoid arthritis
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Toxoplasmosis
,
Tuberculosis
,
Type I diabetes mellitus
💬
[28]
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lecti
...
[1]
96
96
💬
8.
STELARA
- 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO
×
Disease ID
Name
96
Crohn disease
9
STELARA
- 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML
STELARA
- 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMP
...
[1]
Ustekinumab
Ustekinumab
(
Stelara
)
[1]
Ustekinumab
Ustekinumab
(
Stelara
(TN))
💬
9.
STELARA
- 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML
×
Name
Other Names
Ustekinumab
Ustekinumab (USAN/INN)
Ustekinumab (genetical recombination) (JAN)
Stelara (TN)
[3]
IL12A
IL12A
,
IL12B
,
IL23A
💬
9.
STELARA
- 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML
×
Name
Full Name
IL12A
interleukin 12A
IL12B
interleukin 12B
IL23A
interleukin 23 subunit alpha
[28]
African trypanosomiasis
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Herpes simplex virus 1 infection
,
Inflammatory bowel disease
,
Influenza A
,
JAK-STAT signaling pathway
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Malaria
,
Measles
,
Pathways in cancer
,
Pertussis
,
Proteoglycans in cancer
,
RIG-I-like receptor signaling pathway
,
Rheumatoid arthritis
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Toxoplasmosis
,
Tuberculosis
,
Type I diabetes mellitus
💬
[28]
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lecti
...
[1]
96
96
💬
9.
STELARA
- 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML
×
Disease ID
Name
96
Crohn disease
10
STELARA
- 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO
STELARA
- 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLA
...
[1]
Ustekinumab
Ustekinumab
(
Stelara
)
[1]
Ustekinumab
Ustekinumab
(
Stelara
(TN))
💬
10.
STELARA
- 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO
×
Name
Other Names
Ustekinumab
Ustekinumab (USAN/INN)
Ustekinumab (genetical recombination) (JAN)
Stelara (TN)
[3]
IL12A
IL12A
,
IL12B
,
IL23A
💬
10.
STELARA
- 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO
×
Name
Full Name
IL12A
interleukin 12A
IL12B
interleukin 12B
IL23A
interleukin 23 subunit alpha
[28]
African trypanosomiasis
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Herpes simplex virus 1 infection
,
Inflammatory bowel disease
,
Influenza A
,
JAK-STAT signaling pathway
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Malaria
,
Measles
,
Pathways in cancer
,
Pertussis
,
Proteoglycans in cancer
,
RIG-I-like receptor signaling pathway
,
Rheumatoid arthritis
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Toxoplasmosis
,
Tuberculosis
,
Type I diabetes mellitus
💬
[28]
African trypanosomiasis
,
Alcoholic liver disease
,
Allograft rejection
,
Amoebiasis
,
C-type lecti
...
[2]
96
96
,
97
💬
10.
STELARA
- 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO
×
Disease ID
Name
96
Crohn disease
97
Ulcerative colitis